Goodwin advised Magenta on the offering Magenta Therapeutics (“MGTA”), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to…
Magenta Therapeutics’s Initial Public Offering
Goodwin advised Magenta on the offering Magenta Therapeutics (“MGTA”), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to…